Akathisia induced by concurrent use of mirogabalin and sulfamethoxazole-trimethoprim: a case report
Abstract Background Mirogabalin and trimethoprim-sulfamethoxazole (TMP/SMX) are frequently used as supportive purpose during and/or after chemotherapy. Mirogabalin is used to treat neuropathic pain, whereas TMP/SMX is used to prevent pneumocystis pneumonia (PCP) in patients who are immunocompromised...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMC
2026-04-01
|
| Цуврал: | Journal of Pharmaceutical Health Care and Sciences |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1186/s40780-026-00578-y |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
